Brief: Mersana Therapeutics Announces Partial Clinical Hold On Up-Next And Upgrade-A Clinical Trials

Mersana Therapeutics

15/06/2023 12:49

June 15 (Reuters) - Mersana Therapeutics Inc  MRSN.O :
    * MERSANA THERAPEUTICS ANNOUNCES PARTIAL CLINICAL HOLD ON
UP-NEXT
AND UPGRADE-A CLINICAL TRIALS
    * MERSANA THERAPEUTICS INC - FDA HAS ISSUED A PARTIAL
CLINICAL
HOLD PAUSING NEW PATIENT ENROLLMENT IN UP-NEXT AND UPGRADE-A
    * MERSANA THERAPEUTICS INC - PLANS TO SUBMIT TO FDA UPLIFT
SAFETY
AND EFFICACY DATA ONCE AVAILABLE
    * MERSANA THERAPEUTICS INC - PATIENTS WHO ARE ALREADY
ENROLLED IN
TRIALS MAY CONTINUE RECEIVING UPRI
    * MERSANA THERAPEUTICS INC - EXPECTS TO LOCK ITS UPLIFT
CLINICAL
TRIAL DATABASE AND DISCLOSE UPLIFT TOP-LINE DATA BY EARLY
AUGUST.
    * MERSANA THERAPEUTICS INC - PLANS TO SEEK ALIGNMENT WITH
FDA TO
LIFT PARTIAL CLINICAL HOLD AND RESUME ENROLLMENT IN UP-NEXT AND
UPGRADE-A

Source text for Eikon:  ID:nGNXbFkPWM 
Further company coverage:  MRSN.O